Global Bifidobacteria Probiotic 麻豆原创 Growth 2025-2031

Publication ID:

LPI03257690

Publication Date:

March 4, 2025

Pages:

121

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bifidobacteria Probiotic market size is predicted to grow from US$ 148 million in 2025 to US$ 180 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Bifidobacteria are a group of bacteria called probiotics that normally live in your intestines and stomach. They help your body perform essential functions such as digestion and staving off harmful bacteria.
The Bifidobacteria Probiotic 麻豆原创 refers to the industry involved in the production and distribution of probiotic products containing Bifidobacterium strains. Bifidobacteria are a type of beneficial bacteria that naturally reside in the human gastrointestinal tract and are known for their potential health benefits. Probiotics are live microorganisms that, when consumed in adequate amounts, provide health benefits to the host. Bifidobacteria strains are commonly used in probiotic supplements and foods due to their ability to support digestive health and boost the immune system. The market for Bifidobacteria probiotics has been expanding as consumers become more aware of the importance of gut health and seek natural ways to enhance their overall well-being. These products can come in various forms, including capsules, tablets, powders, and even added to food and beverages. Key drivers of the Bifidobacteria probiotic market include the growing interest in preventive healthcare, rising demand for natural and functional foods, and increasing research supporting the benefits of probiotics on gut health. The market is highly competitive, with numerous manufacturers and brands offering different formulations and probiotic strains. In addition to the consumer market, Bifidobacteria probiotics are also used in the pharmaceutical industry and in animal feed to promote gut health in livestock. The market outlook for Bifidobacteria probiotics is expected to remain positive as the interest in natural health products continues to grow, and scientific research further explores the potential benefits of these probiotic strains.
The 鈥淏ifidobacteria Probiotic Industry Forecast鈥� looks at past sales and reviews total world Bifidobacteria Probiotic sales in 2024, providing a comprehensive analysis by region and market sector of projected Bifidobacteria Probiotic sales for 2025 through 2031. With Bifidobacteria Probiotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bifidobacteria Probiotic industry.
This Insight Report provides a comprehensive analysis of the global Bifidobacteria Probiotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bifidobacteria Probiotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bifidobacteria Probiotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bifidobacteria Probiotic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bifidobacteria Probiotic.
This report presents a comprehensive overview, market shares, and growth opportunities of Bifidobacteria Probiotic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Dry
Liquid
Segmentation by Application:
Hypermarket/Supermarket
Medical Stores
Specialty Stores
Online Stores
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BioGaia AB
Probi AB
DowDuPont Inc.
Nestl茅 S.A.
Procter & Gamble Company
Probiotics International Limite
Lallemand Inc
PharmaCare Laboratories
Dr. Willmar Schwabe Group
SymbioPharm GmbH
Pfizer
Incal Health
mitushi biopharma
Goerlich Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bifidobacteria Probiotic market?
What factors are driving Bifidobacteria Probiotic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bifidobacteria Probiotic market opportunities vary by end market size?
How does Bifidobacteria Probiotic break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bifidobacteria Probiotic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bifidobacteria Probiotic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bifidobacteria Probiotic by Country/Region, 2020, 2024 & 2031
2.2 Bifidobacteria Probiotic Segment by Type
2.2.1 Dry
2.2.2 Liquid
2.3 Bifidobacteria Probiotic Sales by Type
2.3.1 Global Bifidobacteria Probiotic Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Bifidobacteria Probiotic Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Bifidobacteria Probiotic Sale Price by Type (2020-2025)
2.4 Bifidobacteria Probiotic Segment by Application
2.4.1 Hypermarket/Supermarket
2.4.2 Medical Stores
2.4.3 Specialty Stores
2.4.4 Online Stores
2.5 Bifidobacteria Probiotic Sales by Application
2.5.1 Global Bifidobacteria Probiotic Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Bifidobacteria Probiotic Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Bifidobacteria Probiotic Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bifidobacteria Probiotic Breakdown Data by Company
3.1.1 Global Bifidobacteria Probiotic Annual Sales by Company (2020-2025)
3.1.2 Global Bifidobacteria Probiotic Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Bifidobacteria Probiotic Annual Revenue by Company (2020-2025)
3.2.1 Global Bifidobacteria Probiotic Revenue by Company (2020-2025)
3.2.2 Global Bifidobacteria Probiotic Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Bifidobacteria Probiotic Sale Price by Company
3.4 Key Manufacturers Bifidobacteria Probiotic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bifidobacteria Probiotic Product Location Distribution
3.4.2 Players Bifidobacteria Probiotic Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Bifidobacteria Probiotic by Geographic Region
4.1 World Historic Bifidobacteria Probiotic 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Bifidobacteria Probiotic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bifidobacteria Probiotic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bifidobacteria Probiotic 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Bifidobacteria Probiotic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bifidobacteria Probiotic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bifidobacteria Probiotic Sales Growth
4.4 APAC Bifidobacteria Probiotic Sales Growth
4.5 Europe Bifidobacteria Probiotic Sales Growth
4.6 Middle East & Africa Bifidobacteria Probiotic Sales Growth
5 Americas
5.1 Americas Bifidobacteria Probiotic Sales by Country
5.1.1 Americas Bifidobacteria Probiotic Sales by Country (2020-2025)
5.1.2 Americas Bifidobacteria Probiotic Revenue by Country (2020-2025)
5.2 Americas Bifidobacteria Probiotic Sales by Type (2020-2025)
5.3 Americas Bifidobacteria Probiotic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bifidobacteria Probiotic Sales by Region
6.1.1 APAC Bifidobacteria Probiotic Sales by Region (2020-2025)
6.1.2 APAC Bifidobacteria Probiotic Revenue by Region (2020-2025)
6.2 APAC Bifidobacteria Probiotic Sales by Type (2020-2025)
6.3 APAC Bifidobacteria Probiotic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bifidobacteria Probiotic by Country
7.1.1 Europe Bifidobacteria Probiotic Sales by Country (2020-2025)
7.1.2 Europe Bifidobacteria Probiotic Revenue by Country (2020-2025)
7.2 Europe Bifidobacteria Probiotic Sales by Type (2020-2025)
7.3 Europe Bifidobacteria Probiotic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bifidobacteria Probiotic by Country
8.1.1 Middle East & Africa Bifidobacteria Probiotic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bifidobacteria Probiotic Revenue by Country (2020-2025)
8.2 Middle East & Africa Bifidobacteria Probiotic Sales by Type (2020-2025)
8.3 Middle East & Africa Bifidobacteria Probiotic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidobacteria Probiotic
10.3 Manufacturing Process Analysis of Bifidobacteria Probiotic
10.4 Industry Chain Structure of Bifidobacteria Probiotic
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bifidobacteria Probiotic Distributors
11.3 Bifidobacteria Probiotic Customer
12 World Forecast Review for Bifidobacteria Probiotic by Geographic Region
12.1 Global Bifidobacteria Probiotic 麻豆原创 Size Forecast by Region
12.1.1 Global Bifidobacteria Probiotic Forecast by Region (2026-2031)
12.1.2 Global Bifidobacteria Probiotic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bifidobacteria Probiotic Forecast by Type (2026-2031)
12.7 Global Bifidobacteria Probiotic Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BioGaia AB
13.1.1 BioGaia AB Company Information
13.1.2 BioGaia AB Bifidobacteria Probiotic Product Portfolios and Specifications
13.1.3 BioGaia AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BioGaia AB Main Business Overview
13.1.5 BioGaia AB Latest Developments
13.2 Probi AB
13.2.1 Probi AB Company Information
13.2.2 Probi AB Bifidobacteria Probiotic Product Portfolios and Specifications
13.2.3 Probi AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Probi AB Main Business Overview
13.2.5 Probi AB Latest Developments
13.3 DowDuPont Inc.
13.3.1 DowDuPont Inc. Company Information
13.3.2 DowDuPont Inc. Bifidobacteria Probiotic Product Portfolios and Specifications
13.3.3 DowDuPont Inc. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 DowDuPont Inc. Main Business Overview
13.3.5 DowDuPont Inc. Latest Developments
13.4 Nestl茅 S.A.
13.4.1 Nestl茅 S.A. Company Information
13.4.2 Nestl茅 S.A. Bifidobacteria Probiotic Product Portfolios and Specifications
13.4.3 Nestl茅 S.A. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nestl茅 S.A. Main Business Overview
13.4.5 Nestl茅 S.A. Latest Developments
13.5 Procter & Gamble Company
13.5.1 Procter & Gamble Company Company Information
13.5.2 Procter & Gamble Company Bifidobacteria Probiotic Product Portfolios and Specifications
13.5.3 Procter & Gamble Company Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Procter & Gamble Company Main Business Overview
13.5.5 Procter & Gamble Company Latest Developments
13.6 Probiotics International Limite
13.6.1 Probiotics International Limite Company Information
13.6.2 Probiotics International Limite Bifidobacteria Probiotic Product Portfolios and Specifications
13.6.3 Probiotics International Limite Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Probiotics International Limite Main Business Overview
13.6.5 Probiotics International Limite Latest Developments
13.7 Lallemand Inc
13.7.1 Lallemand Inc Company Information
13.7.2 Lallemand Inc Bifidobacteria Probiotic Product Portfolios and Specifications
13.7.3 Lallemand Inc Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lallemand Inc Main Business Overview
13.7.5 Lallemand Inc Latest Developments
13.8 PharmaCare Laboratories
13.8.1 PharmaCare Laboratories Company Information
13.8.2 PharmaCare Laboratories Bifidobacteria Probiotic Product Portfolios and Specifications
13.8.3 PharmaCare Laboratories Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 PharmaCare Laboratories Main Business Overview
13.8.5 PharmaCare Laboratories Latest Developments
13.9 Dr. Willmar Schwabe Group
13.9.1 Dr. Willmar Schwabe Group Company Information
13.9.2 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Portfolios and Specifications
13.9.3 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Dr. Willmar Schwabe Group Main Business Overview
13.9.5 Dr. Willmar Schwabe Group Latest Developments
13.10 SymbioPharm GmbH
13.10.1 SymbioPharm GmbH Company Information
13.10.2 SymbioPharm GmbH Bifidobacteria Probiotic Product Portfolios and Specifications
13.10.3 SymbioPharm GmbH Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SymbioPharm GmbH Main Business Overview
13.10.5 SymbioPharm GmbH Latest Developments
13.11 Pfizer
13.11.1 Pfizer Company Information
13.11.2 Pfizer Bifidobacteria Probiotic Product Portfolios and Specifications
13.11.3 Pfizer Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Pfizer Main Business Overview
13.11.5 Pfizer Latest Developments
13.12 Incal Health
13.12.1 Incal Health Company Information
13.12.2 Incal Health Bifidobacteria Probiotic Product Portfolios and Specifications
13.12.3 Incal Health Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Incal Health Main Business Overview
13.12.5 Incal Health Latest Developments
13.13 mitushi biopharma
13.13.1 mitushi biopharma Company Information
13.13.2 mitushi biopharma Bifidobacteria Probiotic Product Portfolios and Specifications
13.13.3 mitushi biopharma Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 mitushi biopharma Main Business Overview
13.13.5 mitushi biopharma Latest Developments
13.14 Goerlich Pharma
13.14.1 Goerlich Pharma Company Information
13.14.2 Goerlich Pharma Bifidobacteria Probiotic Product Portfolios and Specifications
13.14.3 Goerlich Pharma Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Goerlich Pharma Main Business Overview
13.14.5 Goerlich Pharma Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.